ENDOLOGIX, INC.
|
(Exact name of registrant as specified in its charter)
|
Delaware
|
|
000-28440
|
|
68-0328265
|
(State or other jurisdiction of incorporation)
|
|
(Commission File Number)
|
|
(I.R.S. Employer Identification No.)
|
2 Musick, Irvine, CA
|
|
92618
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Registrant's telephone number, including area code:
(949) 595-7200
|
|
N/A
|
(Former name or former address, if changed since last report)
|
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Name
|
2018 Base Salary
|
Target Percentage
|
Target Cash Bonus
|
John McDermott
|
$572,000
|
100%
|
$ 572,500
|
Vaseem Mahboob
|
$380,000
|
55%
|
$ 209,000
|
Michael Chobotov
|
$310,000
|
45%
|
$ 139,500
|
Name
|
Company Performance Objectives
% of Total Cash Bonus
|
MBOs
% of Total Cash Bonus
|
John McDermott
|
100%
|
0%
|
Vaseem Mahboob
|
70%
|
30%
|
Michael Chobotov
|
70%
|
30%
|
Company Performance Objectives
|
% of Company Performance Objective
|
|
|
Financial Performance Objectives
|
|
Sales and Expenses
|
50%
|
|
|
Non-Financial Performance Objectives
|
|
Quality, Compliance, and New Product Development
|
50%
|
|
|
TOTAL
|
100%
|
|
|
ENDOLOGIX, INC.
|
|
|
|
Date: January 31, 2018
|
|
/s/ Vaseem Mahboob
|
|
|
Vaseem Mahboob
|
|
|
Chief Financial Officer
|